Patient-reported Outcomes in the Treatment of Schizophrenia

Phase 3

Completed

• Conditions: Schizophrenia

• Registration Number: NCT00230828
• Lead Sponsor: Solvay Pharmaceuticals

Brief Summary

Patient-reported health economic outcomes for patients enrolled in S1543003 and S1543004 protocols

Detailed Description

Not available

Study Timeline

• Study Start: 2005-05
• Study First Submitted: 2005-09-12
• Study First Submitted QC: 2005-09-30
• Study First Posted: 2005-10-03
• Primary Completion: 2006-01
• Status Verified: 2007-09
• Last Update Submitted: 2013-09-11
• Last Update Posted: 2013-09-12

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

• Participate in S1543003 and S1543004 in the U.S. sites

Exclusion Criteria

• Participate in S1543003 and S1543004 other than U.S. sites

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL